The Conrad
New York, NY
Venable is sponsoring ACI's 13th Annual Paragraph IV Disputes, being held at The Conrad in New York on April 29-30. Venable partner Christina Schwarz will be speaking on a panel, "The Present State of Paragraph IV Litigation and Its Impact on the Pharmaceutical Industry: Legal Analyses and Business Prognoses." The panel will cover the following topics:
- Investigating the most popular districts, filing trends, settlements, and timings
- Examining how judicial shortages in key districts are impacting ANDA litigation and venue selection
- Understanding how this is influencing PTAB filings
- Analyzing the connection between recent Paragraph IV filings and the speed of ANDA approvals
- Studying IPR outcomes of Orange Book patents and appreciating the correlation with District Court litigation
- Exploring when settlement is considered as a favorable outcome in an IPR and its consequences for related District Court litigation
- Understanding how ANDA litigation outcomes affect business forecasts in this next era of the patent cliff
- Appreciating how Paragraph IV outcomes impact business decisions, including R&D, licensing, M&A activity, and beyond
Venable partner Daniel Minion will be speaking on a panel, "The Evolving Induced Infringement Analysis." This panel will cover the following topics:
- Examining precedent where courts have found inducement to exist when there is an element of inevitability resulting in infringement
- Surveying decisions on infringement based on drug labels for support of execution of the infringing acts
- Identifying strategic considerations of labeling language based on this new jurisprudence